Publishing research using ab6301? Please let us know so that we can cite the reference in this datasheet.

ab6301 has been referenced in 9 publications.

  • Rodríguez-Fernández L  et al. Isoform-specific function of calpains in cell adhesion disruption: studies in postlactational mammary gland and breast cancer. Biochem J 473:2893-909 (2016). PubMed: 27402795
  • Wang T  et al. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells. J Biol Chem 290:448-56 (2015). PubMed: 25404731
  • Bag S  et al. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer. J Clin Pathol 68:605-13 (2015). PubMed: 26038241
  • Flowers A  et al. NT-020 treatment reduces inflammation and augments Nrf-2 and Wnt signaling in aged rats. J Neuroinflammation 12:174 (2015). IHC ; Rat . PubMed: 26376629
  • Kotula JW  et al. Targeted Disruption of ß-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth. PLoS One 9:e93441 (2014). WB ; Human . PubMed: 24736311
  • Das RK  et al. Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis. Exp Mol Pathol 95:259-69 (2013). IHC-P ; Human . PubMed: 23994666
  • Yu X  et al. Cilia-driven fluid flow as an epigenetic cue for otolith biomineralization on sensory hair cells of the inner ear. Development 138:487-94 (2011). IHC-P ; Zebrafish . PubMed: 21205793
  • Srinivas BP  et al. A conserved molecular pathway mediates myoblast fusion in insects and vertebrates. Nat Genet 39:781-6 (2007). PubMed: 17529975
  • Kirmizis A  et al. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther 2:113-21 (2003). EMSA ; Human . PubMed: 12533679

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"